Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025 GlobalData Feb 7, 2025 Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…
FDA expands authorisation of two monoclonal antibodies for treatment and post-exposure prevention… EP News Bureau Dec 6, 2021 Amlanivimab and Etesevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2,…
Eli Lilly’s migraine treatment wins US FDA approval Reuters Oct 15, 2019 The drug has been approved to treat acute migraine with or without aura, a sensory phenomenon or visual disturbance, in adults
